EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Flotek Industries, Inc.
FTK

FTK Flotek Industries, Inc.

Flotek Industries, Inc. · NYSE
Market Closed
27.33
▼ ⁦-0.33%⁩ (-0.09)
Market Cap$988.7M
Beta1.48
52w Low52w High
10.9538.89
Last Week
⁦+16.94%⁩
Last Month
⁦-22.84%⁩
Last 3 Months
⁦+34.30%⁩
Last Year
⁦+125.12%⁩
EL7 Factor Analysis
How we score this
Overall86
Excellent — top fifth of the marketHigh FlyerF 4/9SafeBetter than 86% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
24
27.5x▼17.8xBottom tier
▸
Growth
91
36.8%▲7.1%Top tier
▸
Quality
62
29.4%▲4.5%Around median
▸
Safety
66
1.0x▲2.6xTop tier
▸
Capital Return
69
—2.12%Top tier
▸
Momentum
86
198.9%▲2.9%Top tier
▸
Sentiment
64
33Around median
Fair Value
Low confidenceCurrent price$27
Analyst target · 1 analysts
$32
⁦+17%⁩
See it undervalued
Range ⁦$28–$40⁩
vs
DCF (estimate)
N/A (negative FCF)

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 1 analysts setting price target
$33.17
⁦+21.4%⁩
Current Price $27.33·Median $32.00
Low
$27.50
High
$40.00
Current price
$27.33
Average target
$33.17
Street summary

Target Price Revision Analysis for Flotek Industries (FTK) Stock

Bullish tilt

The stock has seen a notable positive revision in its average target price over the past thirty days, with the consensus rising from 26.25 to 33.75, an increase of 28.57%. Despite this upward adjustment, the stock is currently trading at 37.17, a level exceeding the average stated targets, indicating that current price momentum has surpassed conservative analyst expectations, while remaining below the high target of 40.

As of 2026-08-12
Revisions momentum · 30d
⁦-1.7%⁩
Average rating
★ 4.00
Buy
Analyst coverage
6
Buy conviction
100%
High
Target dispersion
46%
Wide
Analyst ratings over time6 analysts rating
6
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months4.00 → 4.00
Recent analyst moves
  • = Reiterate2026-08-05
    Lake Street
    Buy
  • = Reiterate2026-06-22
    Alliance Global Partners
    Buy
  • = Reiterate2026-01-29
    Lake Street
    Buy· $25.00
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    27.49x
    3.56x28.47x
    Above average
  • Forward P/E
    28.10x
    3.36x26.89x
    Expensive
  • EV / EBITDA
    25.70x
    2.12x16.98x
    Very expensive
  • FCF Yield
    -0.5%
    -21.0%15.7%
    Above average
  • Revenue Growth YoY
    36.8%
    -19.7%63.1%
    Above average
  • EPS Growth YoY
    120.9%
    -141.8%256.7%
    Above average
  • Gross Margin
    24.7%
    7.8%72.1%
    Below average
  • ROIC
    29.4%
    -12.7%20.6%
    Exceptional
  • Net Debt / EBITDA
    1.04x
    0.40x3.19x
    Low debt
  • Dividend Yield
    —
    —
  • Payout Ratio
    —
    —
  • Altman Z-Score
    4.75
    -1.814.34
    Exceptional
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-08-05 data

Company Overview

Flotek Industries operates at the intersection of energy services and technology through two primary segments: specialized chemistry technologies and data analytics as a service. The Chemistry segment generates revenue from prescribed chemistry management solutions for oil and gas operations, while the Data Analytics segment provides real-time gas quality measurement, control, blending, and fuel management through the PWRtek platform and XSPCT and Smart Skid devices, targeting electric fracturing fleets, power plants, and behind-the-meter energy projects.

In Q2 of fiscal year 2026, revenue reached $99.4 million, up 70% year over year according to the earnings call, and the company recorded gross profit of $23.8 million, a gross margin of approximately 24%, net income of $10.0 million, and earnings per share of $0.26. Compared with Q1 of fiscal year 2026, revenue increased from $70.1 million, gross profit from $15.5 million, and net income from $4.7 million.

The Data Analytics segment represented 19% of Q2 fiscal year 2026 revenue, or approximately $18.9 million, but generated 51% of the company’s gross profit, highlighting its high profitability relative to its size. Meanwhile, Chemistry activities accounted for most of the revenue, with International Chemistry revenue reaching $10.6 million, up 172% year over year, while Data Analytics segment revenue rose 223% year over year and reached the highest quarterly level in the company’s history.

What's Driving the Stock

  • On September 9, 2026, Flotek raised its fiscal year 2026 revenue guidance to a range of $360 million to $370 million and increased its adjusted EBITDA guidance to between $50 million and $54 million, driven by International Chemistry momentum and expectations that its sales will exceed $40 million in the second half of fiscal year 2026.
Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

International Chemistry revenue rose in Q2 of fiscal year 2026 to $10.6 million from $1.9 million in the previous quarter, an increase of more than 450% sequentially, and alone reached 93% of the total International Chemistry revenue of $11.4 million recorded in fiscal year 2025.
  • The Data Analytics segment grew 223% year over year in Q2 of fiscal year 2026 and became responsible for 51% of gross profit despite contributing only 19% of revenue; 63% of the segment’s revenue also came from external customers, compared with 44% a year earlier.
  • The number of digital validation measurement devices deployed or contracted for delivery increased from 57 devices at the end of Q1 of fiscal year 2026 to 89 devices at the end of Q2, an increase of 56%, after the XSPCT analyzer was selected as Product of the Year at the Analyzer Technology Conference in March 2026.
  • The company expects its measurement or control solutions to cover more than 5 gigawatts of power capacity by Q1 of fiscal year 2027, while the value of potential business-line opportunities in the bidding and negotiation stages exceeded $1 billion according to management; however, these opportunities are not contracted revenue and do not guarantee that they will be won.
  • Buying & Selling Case

    ▲ Buying Case4 pts

    • +Q2 fiscal year 2026 results showed simultaneous growth in scale and profitability, with revenue of $99.4 million, gross profit of $23.8 million, and net income of $10.0 million, while adjusted EBITDA rose 109% year over year to $16.8 million.
    • +The shift in the profit mix toward Data Analytics enhances the quality of growth; the segment generated 51% of gross profit in Q2 of fiscal year 2026 despite representing only 19% of revenue, benefiting from measurement and control services and recurring subscriptions.
    • +International expansion in Chemistry provides a parallel growth driver, with the company’s solutions operating on four fracturing units in the Jafurah field and the potential to expand to six units by the end of fiscal year 2026, under a scope of work that management said has more than four and a half years remaining.
    • +Operating efficiency improved as general and administrative expenses declined to less than 8% of revenue in Q2 of fiscal year 2026, compared with approximately 12% a year earlier, and the company said its leverage ratio was below one turn based on net debt as of June 30, 2026, and the midpoint of adjusted EBITDA guidance.

    ▼ Selling Case6 pts

    • −The 400-megawatt power project in Puerto Rico was canceled according to an August 28, 2026 report, after the company had announced a ten-year contract related to the project on August 3, 2026; therefore, the previously announced contract value should not be included in future growth without new contractual disclosure.
    • −Some domestic Chemistry revenue depends on transactions that do not recur consistently over time; Chemistry revenue in June 2026 alone was approximately $31 million, and work was shifted from July to June, prompting management on the August 5, 2026 call to assume a more moderate pace for the second half of fiscal year 2026.
    • −Flotek had not secured an extension of the second phase of the Montana energy services contract as of the August 5, 2026 call, so its revenue was excluded from Q4 of fiscal year 2026 in the guidance in place at that time; the contract contributed approximately $6 million to Q2 revenue, making a failure to extend it a tangible risk to the Data segment’s growth trajectory.
    • −Gross margin was approximately 24% in Q2 of fiscal year 2026, down less than 100 basis points year over year despite 70% revenue growth, and management also explained that the power-generation equipment leasing model carries lower margins than the equipment ownership model.
    • −The acceleration of Middle East business placed the supply chain under pressure during Q2 of fiscal year 2026, while continued strength in international revenue was tied to inventory shipments arriving during August and possibly September 2026; therefore, any disruption in supply or delivery timing could affect revenue recognition.
    • −The stock’s 52-week range extends from $11.09 to $39.67, while analysts’ valuations range from $27.50 to $40; the breadth of both ranges indicates high sensitivity to changes in contract and growth expectations, particularly after the Puerto Rico project was canceled despite the increase in fiscal year 2026 guidance.

    Valuation

    The analyst consensus is “Buy,” with an average price target of $33.17 and a target range of $27.50 to $40. The average target is approximately 16% below the 52-week high of $39.67, while the highest target is close to that high, reflecting positive but uneven growth expectations. The increase in fiscal year 2026 guidance should be weighed against the cancellation of the Puerto Rico project and the wide target range, both of which increase the valuation’s sensitivity to actual growth execution.

    BuyAnalyst target: $33.17(+21.4%)

    Figures in the text are as of 2026-09-09; the live price is shown at the top of the page.

    FAQ

    What is Flotek Industries’ primary business, and what is its ticker symbol?

    Flotek Industries trades on the NYSE under the ticker FTK. The company combines specialized chemistry solutions with real-time data analytics for the energy and infrastructure sectors. Its products and platforms include PWRtek, XSPCT, and Smart Skid, which are used to measure, blend, and control gas quality and improve equipment efficiency. The Data Analytics segment represented 19% of Q2 fiscal year 2026 revenue and 51% of gross profit.

    How did Flotek perform in Q2 of fiscal year 2026?

    Q2 fiscal year 2026 revenue was approximately $99.4 million, the company’s strongest quarterly result in ten years according to management. Gross profit was $23.8 million, equivalent to a margin of approximately 24%. Net income was $10.0 million and earnings per share were $0.26, compared with net income of $4.7 million and earnings per share of $0.12 in Q1 of fiscal year 2026. Adjusted EBITDA also reached $16.8 million, up 109% year over year.

    What is Flotek’s guidance for fiscal year 2026?

    On September 9, 2026, Flotek raised its fiscal year 2026 revenue guidance to between $360 million and $370 million. It also raised its adjusted EBITDA range to between $50 million and $54 million. The update was based on growth in international sales, with International Chemistry revenue expected to exceed $40 million during the second half of fiscal year 2026. The previous update published on August 28, 2026 projected revenue of between $340 million and $350 million and adjusted EBITDA of between $47 million and $51 million.

    Why is the Data Analytics segment important to the FTK growth story?

    The segment’s revenue increased 223% year over year in Q2 of fiscal year 2026, and its services revenue alone exceeded the segment’s total revenue in the comparable period. External customers accounted for 63% of the segment’s revenue, compared with 44% a year earlier, and the Montana contract contributed approximately $6 million during the quarter. The number of digital validation devices deployed or under contract increased from 57 to 89 devices between the ends of Q1 and Q2 of fiscal year 2026. The company also plans to have more than 5 gigawatts under measurement or control by Q1 of fiscal year 2027.

    What is the impact of the Puerto Rico project cancellation on the Flotek investment thesis?

    Flotek had announced on August 3, 2026 a ten-year agreement to support a 400-megawatt power project using the PWRtek platform and Smart Skid equipment. However, a report dated August 28, 2026 stated that the project had been canceled, so the previously announced contract value should not be relied upon when estimating future revenue. In contrast, the company raised its fiscal year 2026 guidance again on September 9, 2026 to revenue of between $360 million and $370 million and adjusted EBITDA of between $50 million and $54 million. This leaves the growth thesis more dependent on International Chemistry, Data Analytics, and other contracts that actually convert into revenue.

    What are the key operating risks to monitor at Flotek?

    Domestic Chemistry revenue is volatile, with June 2026 alone recording approximately $31 million after some July work was shifted into June. The extension of the second phase of the Montana contract also had not been secured as of August 5, 2026, despite contributing approximately $6 million to Q2 fiscal year 2026 revenue. The supply chain came under pressure because of accelerating Middle East business, and continued international momentum depended on inventory shipments arriving in August and possibly September 2026. Gross margin also declined by less than 100 basis points year over year to approximately 24% despite the sharp increase in revenue.